Targeting one protein to treat two neurodegenerative diseases

Disrupting production of ataxin-2 with antisense technology improves symptoms of ALS and spinocerebellar ataxia type 2 in mice

via Chemical & Engineering News: Biological SCENE http://ift.tt/2p7f0kt